RT @AurelieRheumo: Izokibep Phase 2 in active PsA at Wk 16 results (80mg dose): âï¸ACR50 52% âï¸PASI 90 50% âï
Tweet Content
Izokibep Phase 2 in active PsA at Wk 16 results (80mg dose):
⭐️ACR50 52%
⭐️PASI 90 50%
⭐️Resolution of enthesitis LEI 88%
⭐️Safety profile similar to what observed in PsO.
Promising for the enthesitis domain!
@RheumNow OP0258 #EULAR2022 https://t.co/Wm3MvVQzoP
Show on Archive Page
On
Display in Search Results
On
PDQ
Off